Summit Therapeutics Stock Target Price and Analyst Consensus
| SMMT Stock | USD 22.36 0.72 3.33% |
The current analyst and expert consensus on Summit Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected Summit Therapeutics target price consensus is 32.15 with 7 analyst opinions. Check out Macroaxis Advice on Summit Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Summit Therapeutics PLC analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Summit Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Summit Therapeutics. We strongly encourage you to use your own analysis of Summit Therapeutics PLC to validate this buy or sell advice. Summit Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Summit Therapeutics PLC target price to derive its highest and lowest estimates based on projected price volatility of 4.6112.
Lowest Forecast 29.26 | Highest Forecast 35.68 | Target Price 32.15 |
Summit |
It's important to approach Summit Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Summit Therapeutics Target Price Consensus
Summit target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Summit Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Strong Buy |
Most Summit analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Summit stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Summit Therapeutics PLC, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationSummit Therapeutics Target Price Projection
Summit Therapeutics' current and average target prices are 22.36 and 32.15, respectively. The current price of Summit Therapeutics is the price at which Summit Therapeutics PLC is currently trading. On the other hand, Summit Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Summit Therapeutics Market Quote on 31st of January 2025
Target Price
Analyst Consensus On Summit Therapeutics Target Price
Summit Therapeutics Analyst Ratings
Summit Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Summit Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Summit Therapeutics' financials, market performance, and future outlook by experienced professionals. Summit Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Summit Therapeutics price targets
Summit Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Summit Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Summit Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Summit Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Summit Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Summit Therapeutics is a key component of Summit Therapeutics valuation and have some predictive power on the future returns of a Summit Therapeutics.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested over 300 shares | |
 | Momentum Invested over 50 shares | |
 | Business Services Invested over 100 shares | |
 | Social Domain Invested few shares | |
 | Banking Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
 | Automobiles and Trucks Invested over 300 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Investor Favorites Invested over 300 shares | |
 | Manufacturing Invested over 30 shares | |
Additional Tools for Summit Stock Analysis
When running Summit Therapeutics' price analysis, check to measure Summit Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Summit Therapeutics is operating at the current time. Most of Summit Therapeutics' value examination focuses on studying past and present price action to predict the probability of Summit Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Summit Therapeutics' price. Additionally, you may evaluate how the addition of Summit Therapeutics to your portfolios can decrease your overall portfolio volatility.